Published on: April 28, 2020
For women with a certain genetic makeup, being overweight or obese significantly raises the risk for colorectal cancer, according to a recent study published in JNCI: Journal of the National Cancer Institute.
Published on: March 2, 2020
To help both the death and diagnosis rates of colorectal cancer drop—and to help those who develop it survive and thrive—the American Cancer Society (ACS) funds the research of scientists across the country who use the latest evidence and cutting-edge technology to help prevent and treat CRC. Here are two of their stories.
Published on: December 30, 2019
Here’s a look at some of the significant advances in cancer research from the past 10 years that are helping to save lives now – and how American Cancer Society staff and funded researchers have contributed to each one.
Published on: November 1, 2019
As of 2016, more than 200 targeted therapies (also called precision medicines) were available in the United States, and more than 2,000 were in the last stages of development—half of them to treat cancer. For many of these drugs, doctors first use genomic testing of the cancer cells to get an idea of whether the treatment will work. Yet, nearly 1 in 4 oncologists rarely or never mention costs when they talk about the need for genomic testing with their cancer patients, according to a new study led by American Cancer Society (ACS) investigators.